Noradrenergic regulation of inflammatory gene expression in brain.
about
The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis ProjectLocus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrineRole of Glia in Stress-Induced Enhancement and Impairment of MemoryTurning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease PathogenesisNorepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors.Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.Effects of inducible nitric oxide synthase inhibition or norepinephrine on the neurovascular coupling in an endotoxic rat shock model.Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease.Degenerative alterations in noradrenergic neurons of the locus coeruleus in Alzheimer's diseaseNorepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performanceEffect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving ratsAge-related neurodegeneration and memory loss in down syndrome.Trait Hostility and Acute Inflammatory Responses to Stress in the Laboratory.Olfaction in Parkinson's disease and related disorders.Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1.Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's diseaseThe Locus Coeruleus: Essential for Maintaining Cognitive Function and the Aging Brain.Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators.Specificity and impact of adrenergic projections to the midbrain dopamine system.Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.Neuromelanin marks the spot: identifying a locus coeruleus biomarker of cognitive reserve in healthy agingAge and duration of inflammatory environment differentially affect the neuroimmune response and catecholaminergic neurons in the midbrain and brainstem.Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model.Cognitive reserve and Alzheimer's disease.Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.Monoaminergic neuropathology in Alzheimer's disease.Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity.Tauopathy in transgenic (SHR72) rats impairs function of central noradrenergic system and promotes neuroinflammation.Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders.IGF-1 regulates cAMP levels in astrocytes through a beta2-adrenergic receptor-dependant mechanism.Ablation of the locus coeruleus increases oxidative stress in tg-2576 transgenic but not wild-type mice.Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediatorsNorepinephrine-mediated suppression of phagocytosis by wound neutrophils.Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration.Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery.
P2860
Q21261508-6C1C5F49-22BF-46A4-9B68-34D8F959C71BQ22248084-E65210D9-B5EA-4A6E-8FD5-77964D6628F9Q26770453-15D1BF11-6007-407C-99FC-67E5FD5746A8Q27027221-C5BA0232-A4FF-43E9-9CAD-8847F16CD9FAQ30540053-D6A62508-C3DB-495F-B819-19207F6841CAQ30835713-F0BDE0DE-04BB-4622-9903-66C026B4EC98Q33497025-0FF9E4F4-9663-45B8-8FA8-51C19F2F289DQ33967306-57E38368-3B9B-448F-ABC6-23D30497B06BQ34095163-F775E8E6-6D66-4E07-9820-727A8F71DE8DQ34283000-06CA0F82-785B-4D07-BE4C-CEE775B14EAEQ35049086-FAD9E1EE-9825-4A29-A587-772F17CDCF9AQ35867093-B585A547-3970-45A4-9E2B-D78992FE1A5AQ36043171-D597CC62-4A76-428D-B64E-0B5A18121809Q36193915-6C55226D-7186-4528-B1ED-EBD6F97E6AD3Q36249492-2339E1A0-E436-4D23-B17D-AEE92378DE05Q36310518-78A677D3-204B-4257-B000-2E3BBE543C56Q36600664-37AD3DA8-60A5-4E92-8ADB-F6FD4EED2F80Q36715802-FACD3F7C-3511-4FC4-924B-17E61B01EDF2Q36932568-8845E677-8EF5-4BAF-991E-CF9DF2A5A15FQ36998284-E74F7099-084E-469D-8C3E-5614F3C68182Q37279515-4B219F3C-3C1D-4F4E-B3E8-3E46BCAAFB63Q37468299-7A3AD24C-DC96-4351-AEEE-D2CBAFB7BEA4Q37624173-A19EA87E-F2AA-46F5-AEFB-2B26EAE3D80DQ37634353-E6EDECCF-DBDB-41A3-9430-C950A288DBADQ37710098-6E3A6BA0-ED58-4131-A404-D0F6E635981FQ38209190-8C2509E8-798B-4156-A07F-F741395A3FCFQ38637324-448F4263-0629-46E3-9279-BBEDB3EF5202Q38809649-8316533E-B37D-4E05-A9C9-0408C55842C6Q38875190-E888719B-216E-48D6-BA64-E559B1477904Q39000210-1A2388F6-D84D-48E3-A3F6-B04AB9CA38BEQ39052041-F117AF32-FAA2-46BE-BF06-C807B060CE53Q39743698-F0F9F72F-876F-4C58-84A0-4EACD8E70EDEQ40080984-9663B1B8-855E-415C-88A5-A45F11724EC0Q41137764-B90564FF-AF59-43E5-B5A8-982CC35ED2DEQ41555471-721FC41A-343E-43E2-9356-E53D5ACC6B9AQ41988079-4D363BA3-3D04-4351-BB53-77E741F51B68Q42441161-8DFB0D98-C830-46C4-943F-FE741042BD2FQ43126051-23F77AAE-9621-4AF5-BC83-4A3E5F4C495AQ46220981-D1E6769E-4F53-4945-94CE-8EEC38123148Q46503348-6938953A-2303-4FBF-9BB0-2CEBA52518F6
P2860
Noradrenergic regulation of inflammatory gene expression in brain.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Noradrenergic regulation of inflammatory gene expression in brain.
@ast
Noradrenergic regulation of inflammatory gene expression in brain.
@en
Noradrenergic regulation of inflammatory gene expression in brain.
@nl
type
label
Noradrenergic regulation of inflammatory gene expression in brain.
@ast
Noradrenergic regulation of inflammatory gene expression in brain.
@en
Noradrenergic regulation of inflammatory gene expression in brain.
@nl
prefLabel
Noradrenergic regulation of inflammatory gene expression in brain.
@ast
Noradrenergic regulation of inflammatory gene expression in brain.
@en
Noradrenergic regulation of inflammatory gene expression in brain.
@nl
P2093
P1476
Noradrenergic regulation of inflammatory gene expression in brain
@en
P2093
Douglas L Feinstein
Guy Weinberg
Michael T Heneka
Vitaliy Gavrilyuk
P304
P356
10.1016/S0197-0186(02)00049-9
P577
2002-11-01T00:00:00Z